Wednesday, June 25, 2014

Controversial cancer doctor gets green light by the FDA to resume clinical treatments

The FDA's decision "marks an important step in the development of antineoplastons for the treatment of various forms of brain tumors," the institute said in its statement.

by Liz Szabo, USA Today

The Food and Drug Administration has given a controversial Houston doctor the green light to resume administering experimental cancer treatments.

The FDA has lifted restrictions on a clinical trial run by Stanislaw Burzynski, who was the subject of a USA TODAY investigation last year. Burzynski, 70, has wrangled with state and federal medical authorities for nearly 40 years over his claims that he has discovered natural substances that can fight certain cancers.

Burzynski — hailed as a maverick by his fans but derided as a snake oil salesman by mainstream doctors — has long claimed to have achieved dramatic success in hard-to-treat cancers, especially brainstem tumors that are usually considered fatal. According to the National Cancer Institute, however, Burzynski has not produced proof that his drugs save lives by publishing a randomized, controlled trial in a peer-reviewed journal.

The FDA placed Burzynski's clinical trial on a partial hold — barring him from enrolling new patients — after the 2012 death of a 6-year-old New Jersey boy in his study.

Last year, the FDA issued a sternly worded warning letter to Burzynski, expressing concern about patient safety and the accuracy of his records. The FDA can lift those restrictions once Burzynski meets its requirements.

Read rest of story

Related articles:
Burzynski Research Institute, Inc. Announces Lifting of the FDA Partial Clinical Hold - Phase 3 Clinical Study Agreed Upon

Burzynski Clinic


Burzynski, the Movie is an internationally award-winning documentary originally released in 2010 (with an Extended Edition released in 2011) that tells the true story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history.

His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and has been given permission by the FDA to begin the final phase of FDA testingrandomized controlled clinical trials.

When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm-shifting medical breakthrough.

Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film who chose these medicines instead of surgery, chemotherapy or radiation - with full disclosure of medical records to support their diagnosis and recovery - as well as systematic (non-anecdotal) FDA-supervised clinical trial data comparing Antineoplastons to other available treatments—which is published within the peer-reviewed medical literature.

One form of cancer - diffuse, intrinsic, childhood brainstem glioma has never before been cured in any scientifically controlled clinical trial in the history of medicine. Antineoplastons hold the first cures in history - dozens of them. [ANP-Childs Nerv Syst. - 2014] [ANP -Pediatric Drugs - 2006] [ANP - PubMed 2003] [ANP - PubMed 2006] [ANP - Cancer Therapy 2007] [Rad & other - PubMed 2008] [Chemo/Rad - PubMed 2005]

This documentary takes the audience through the treacherous, yet victorious, 14-year journey both Dr. Burzynski and his patients have had to endure in order to obtain FDA-approved clinical trials of Antineoplastons.

Dr. Burzynski resides and practices medicine in Houston, Texas. He was able to initially produce and administer his discovery without FDA-approval from 1977-1995 because the state of Texas at this time did not require that Texas physicians be required to adhere to Federal law in this situation. This law has since been changed.

As with anything that changes current-day paradigms, Burzynski's ability to successfully treat incurable cancer with such consistency has baffled the industry. Ironically, this fact had prompted numerous investigations by the Texas Medical Board, who relentlessly took Dr. Burzynski as high as the state supreme court in their failed attempt to halt his practices.

Likewise, the Food and Drug Administration engaged in four Federal Grand Juries spanning over a decade attempting to indict Dr. Burzynski, all of which ended in no finding of fault on his behalf. Finally, Dr. Burzynski was indicted in their 5th Grand Jury in 1995, resulting in two federal trials and two sets of jurors finding him not guilty of any wrongdoing.  If convicted, Dr. Burzynski would have faced a maximum of 290 years in a federal prison and $18.5 million in fines.

However, what was revealed a few years after Dr. Burzynski won his freedom, helps to paint a more coherent picture regarding the true motivation of the United States government's relentless persecution of Stanislaw Burzynski, M.D., Ph.D.
Note: When Antineoplastons are approved for public use, it will allow a single scientist to hold an exclusive right to manufacture and sell these medicines on the open market—potentially leaving the pharmaceutical industry absent in profiting from the most effective gene-targeted cancer treatment the world has ever seen.
The Burzynski Documentary Series is directed and produced by Eric Merola - Read VARIETY's review - Read The Los Angeles Times review

Cancer is Serious Business, The Movie, Part II:


In the compelling follow-up to the internationally award-winning documentary, Burzynski, the Movie; Burzynski: Cancer is Serious Business, Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas.

For most patients undergoing Burzynski's treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many for dead.
As the story unfolds, you will observe a real-time change of hearts and minds from many of these doctors and families. Unlike the first documentary, Part II showcases interviews with board-certified oncologists, surgeons and neurosurgeons, who witnessed patients leave their care, soon to return in great health after opting for the Burzynski Clinic.
Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy which he calls, "Personalized Gene-Targeted Cancer Therapy", where each patient's Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient—vs. the conveyor belt, "one-size-fits-all" approach that current oncology adheres to.

Due to the slow-moving, bureaucratic obstacles enforced on Antineoplastons by America's FDA, this new expanded "personalized gene-targeted" direction has allowed more patients (who are denied access to Antineoplastons) to benefit from Burzynski's practice in ways never before thought possible. And yet, still with similar resistance and controversy endured by Burzynski's Antineoplaston therapy.

The film also takes you to Kurume University in Fukuoka, Japan—where independently designed studies of Antineoplastons have been underway for 27 years—without Dr. Burzynski's (the inventor's) involvement or supervision. Learn how this team of Japanese pathologists, oncologists and surgeons have studied these anti-cancer co mpounds using their own methodologies—resulting in the first ever independently-run randomized controlled clinical trials.

"After twenty-seven years of independently testing Antineoplastons—including randomized clinical trials, we found that Dr. Burzynski was right. It's obviously not anecdotal anymore."

- Hideaki Tsuda, MD - 2013, Kurume Medical University, Fukuoka Prefecture, Japan
You will be placed into the turbulent journey of how the industry utilizes its now usurped regulatory agency to both block Antineoplastons' Phase 3 clinical trial process—and orchestrate a group of "information hit men" (also known as an "Astroturf Campaign") to pollute all channels of public information in an effort to confuse the public over the truth behind Antineoplastons. This international Astroturf group also engages in the intimidation and harassment of prospective and current terminal cancer patients under Dr. Burzynski's care.
However, most notable of all—are the earth-shattering events that occurred upon the final days of production of this film—you'll be left speechless, yet with so much to say, when you witness the story and shocking conclusion to Burzynski: Cancer Is Serious Business, Part II.

"I can't imagine a world where other people will not have the privilege that I have had—the privilege to have their life saved by a new technology that can cure cancer—it's terrifying." 
- Laura Hymas - 2013, Glioblastoma Grade IV brain cancer patient, after experiencing a complete remission under Antineoplaston therapy.
Disclaimer: This documentary film series  is not affiliated with Dr. Stanislaw Burzynski MD, PhD, The Burzynski Clinic, or the Burzynski Research Institute, Inc. It is an independent film series produced by Eric Merola, and should not be misunderstood as an advertisement for the Burzynski Clinic. This film series and this web site is not intended to replace professional medical advice.



Our Amazing Global Economy Can Make You Wealthy and Happy!

 by Madison Reed

Did you know that today more millionaires are being created now than at any time in human history - and that most of them are from internet-related businesses?

I've worked in the integrative health field for more than 20 years.  When I started on my work helping to bring healing to other people, the declaration 'Spirit, Mind & Body Wellness' surfaced to my mind.  "Spirit, Mind & Body Wellness" means, that to attain a state of health and satisfaction, we must allow healing to flow into all aspects of our lives.

Healing is about more than giving the right kind of nutrients to our physical bodies.  Just as we are also emotional and spiritual beings, due to our physical make up, we are grounded and connected to Mother Earth, to billions of other human beings, and to our world economy.  Everything is creation is interconnected.  We are interdependent with everything, and the national and world economic systems exert a profound influence on us.  If we succeed with our jobs, we usually have more money.  And that gives us more options to do what we want to do, and greater satisfaction with life and happiness, which lowers our stress levels.  But most people are not that fortunate.  Having a good job or even having a job, isn't easy to do.  Succeeding is getting more difficult even though all the world's resources are still here, and potential opportunities have never been greater.  The rules are shifting beneath our feet, creating unemployment, more stress and more illness.  So if the mother ship hasn't lifted all the gold, money, resources off the planet, and the homes and businesses are still here, why are so many people slipping, struggling and loosing control?  The answer in short is, the rules have changed.  Now  we have to do things differently.

The trend now among sharp, modern people is to become self-employed.  In the future, people living in Beijing and Minsk; in Atlanta and Panama City, and Riyadh and Moscow, Kampala and Prague, will be happy self-employed people enjoying the best life on our gorgeous Earth has to offer.  They will have freedom like never before in the history of the human race - captains of their own yachts, steering them over the deep tranquil seas of gratitude for being alive.

With the linking of worldwide communication and commerce through the internet, and a little bit of enjoyable learning and effort, it is now quite easy for everyone to create sources of income that will bring independence, mobility and flexibility into your lives with new types of work that we enjoy,  that we can take with us anywhere in the world.  Confined office desks are replaced by smartphone and laptop computers.  We can work at the beach, or at the top of a mountain in a cloud forest.  Or maybe you've been thinking about moving to another country, and you need an income that isn't dependent upon where you live?  Well, it's here.  We are living in an age of miracles, and miracles happen when we align with gratitude, and move out of old patterns into new and refreshing activities!

My guess is that you've been feeling like making a change for a long time.  Right?  So go ahead.  Now is the time to make that deliberate change.  Learn a new fun skill by becoming a successful global internet entrepreneur, right from your home.

That you're still reading this is not a coincidence!  You found my article, because universal synchronicity is at work.  There are no coincidences in life.  You are attracting the change that you need to go to the next level.  EVERYTHING is connected, and as we change, the universe responds by sending us what we have been attracting.  This process is called the Law of Attraction.

 "Within the seed of your desire is everything necessary for it to blossom to fulfillment."  ~Abraham Hicks
I would like to introduce you to the Pure Leverage global community of entrepreneurs.  As a member of our community you will have a team of successful entrepreneurs to help you learn what you need to build a successful internet business in a short time.  You'll also have a suite of tools that are worth a small fortune.  Whether your new direction is toward the independence that only an internet business can bring to you, or you want the tools to rocket your brick and mortar business to new levels of success, I promise you that Pure Leverage is the answer to your prayer.  Check it out and join my team.  We're called "Team Synchronicity."

Pure Leverage is one of the most ingenious systems ever created.  It empowers the poor or the rich.  It's global, and here for all men and woman who wish to tap into the vast wealth of our amazing world economy.



Tuesday, June 17, 2014

Cancer cure-all pill that gives life-long immunity available for human use in a few years

British scientists have discovered a drug which fights all cancers by boosting the body's defences and prevents the disease returning by increasing natural immunity

By , Science Correspondent

A pill which boosts the body’s natural defences could help fight off all cancers and stop them ever returning, scientists believe.

‘Delta-inhibitors’ were already known to help leukaemia patients, but researchers were amazed to find they also work on a whole range of other cancers.

The drugs, which are taken orally as a pill, were so successful in leukaemia trials that the control group, who were taking placebos, were immediately switched to the medication on ethical grounds.

Now, scientists at UCL and the Babraham Institute in Cambridge, have discovered that the same ‘delta inhibitors’ are also effective against lung, pancreatic, skin and breast cancers, and probably many more.

Cancer suppresses the immune system by producing an enzyme called ‘p100delta’ which tells it to power down, making it difficult for the body to fight the disease. The drugs ‘inhibit’ that enzyme, allowing the immune system to attack tumour cells.

The added benefit is that once the body has learned to fight off the cancer, it has in-built immunity, so that the disease can never return, unlike if it had been killed by chemotherapy.

Although the study was conducted in mice, researchers are confident it would work in humans and are hopeful that human trials will begin soon.

“This helps your own immune system fight off the cancer better. The good guys win. And it seems to work on all cancers,” said study co-leader Professor Bart Vanhaesebroeck of the UCL Cancer Institute, who first discovered the p110 delta enzyme in 1997.

“It will work to a certain extent on its own, if the tumour is not too big, but it would be very effective after surgery, to prevent spreading.

“So it is very exciting. We have shown that blocking ‘p110delta’ also has the remarkable effect of boosting the body’s immune response against leukaemias as well as other cancers.”

The team showed that inhibiting the enzyme in mice significantly increased cancer survival rates across a broad range of tumour types, both solid and blood cancers.

Mice given the drug survived breast cancer for almost twice as long.

Their cancers also spread significantly less, with far fewer and smaller tumours developing. Survival after surgical removal of primary breast cancer tumours was also vastly improved, which has important clinical implications for stopping breast cancer from returning following surgery.

And they discovered that the immune system ‘remembers’ the cancer and can fight it off completely again. Mice who were given cancer a second time all survived.

“Our work shows that delta inhibitors can shift the balance from the cancer becoming immune to our body’s defences towards the body becoming immune to the cancer,” said study co-leader Dr Klaus Okkenhaug of the Babraham Institute at Cambridge University.

“This provides a rationale for using these drugs against both solid and blood cancers, possibly alongside cancer vaccines, cell therapies and other treatments that further promote tumour-specific immune responses.”

The drugs are already being used in clinical trials and have been granted Breakthrough Therapy status by the Federal Drugs Agency in the US, which means their development has been speeded up.

They could be available within just a few years if approved by European regulators and the National Institute of Clinical Excellence.

Professor Nic Jones, Cancer Research UK’s chief scientist and director of the Manchester Cancer Research Centre, said: “Treatments that train the immune system to recognise and kill cancer cells are showing huge promise in several types of cancer.

“This new finding, although only at an early stage, offers the potential to develop more treatments that can do this in many more cancers, including ones that have real need for more effective treatments such as pancreatic cancer.”

The study was published in the journal Nature and funded by Cancer Research UK, the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.



Saturday, June 7, 2014

Australia's CSIRO sets world record in generating "supercritical" steam using solar power

CSIRO Heliostat Array as Seen from Tower 2 Photo: CSIRO


In what it is claiming as a world record and breakthrough for solar thermal energy, researchers at Australia's CSIRO have used solar energy to generate "supercritical" steam at its solar thermal test plant in Newcastle, Australia. Using a field of more than 600 directional mirrors (heliostats) directed at two towers housing solar receivers and turbines, the researchers generated steam at a pressure of 23.5 mpa (3,400 psi) and 570° C (1,058° F).

Generating supercritical steam, an ultra-hot, ultra-pressurized steam that’s used to drive the world’s most advanced power plant turbines, has previously only been possible using fossil fuels, such as coal or gas. The CSIRO is touting its generation using solar technology as a breakthrough for solar energy production, with Dr Alex Wonhas, CSIRO's Energy Director, seeing it as a potential revolution for the renewable energy industry.

"It's like breaking the sound barrier; this step change proves solar has the potential to compete with the peak performance capabilities of fossil fuel sources," Dr Wonhas said. "Instead of relying on burning fossil fuels to produce supercritical steam, this breakthrough demonstrates that the power plants of the future could instead be using the free, zero emission energy of the sun to achieve the same result."